| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 8, 2026 | ±2.2% | +0.3% | over-priced |
| November 6, 2025 | ±1.3% | +0.7% | over-priced |
| August 4, 2025 | ±1.9% | +1.1% | over-priced |
| May 5, 2025 | ±2.2% | +0.1% | over-priced |
| November 7, 2024 | ±1.8% | -1.4% | over-priced |
| August 5, 2024 | ±2.2% | -2.8% | under-priced |
| May 6, 2024 | ±2.2% | -0.3% | over-priced |
| November 9, 2023 | ±1.7% | -1.9% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.28 | $2.2B | $358M |
| Q4 FY2025 | $0.92 | $1.8B | $253M |
| Q3 FY2025 | $2.35 | $2.7B | $641M |
| Q2 FY2025 | $1.01 | $2.2B | $277M |
Ameren Corporation (AEE) reports in 100 days, with the next report estimated for September 21, 2026. Across the last 8 reports, options priced an average ±1.9% earnings move while the stock actually moved 1.1% on average — the market has systematically over-priced AEE's earnings risk. Fundamentals into the print: EPS up 19.6% year-over-year, revenue up 3.8%. QuantLogix's live 5-factor engine currently reads AEE as a buy at 65/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →